Finally, silencing of MMP14 in U251 model significantly prolonged survival of mice treated with TMZ+XRT compared to the U251 shScramble (P < 0.009) which results in low glioma proliferation (Fig. 6D, E, and F). The gene discussed is MMP14; the disease is central nervous system cancer.